Recent Asset Acquisitions Intersurgical has recently invested approximately $530 million to acquire the Acute Care and Interventional Urology units, indicating a strategic expansion into critical care and urology markets which presents opportunities for cross-selling specialized respiratory and medical products.

Expanding Geographic Footprint The company is expanding its office presence in Lithuania, demonstrating growth in European markets and increasing its regional operational capacity, which can facilitate localized sales efforts and support for a broader customer base.

Innovative Product Launches Intersurgical continuously introduces new products such as the AccuPAP Therapy System and the i-gel O2 Resus Pack, highlighting ongoing innovation to meet clinical needs and offering sales opportunities for complementary respiratory products and accessories.

Market Focus and Expertise With over 40 years of experience in respiratory care and a comprehensive product portfolio covering airway management, anesthesia, critical care, and oxygen therapy, Intersurgical is well-positioned to meet evolving clinical demands and expand sales through targeted solutions for hospitals and emergency services.

Financial Strength Generated revenue between $500 million and one billion dollars, coupled with recent strategic acquisitions, reflects financial stability and growth potential, indicating a robust foundation for pursuing large-scale hospital, government, and international procurement contracts.